Low expression levels of lncRNA BC200 can be detected in normal tissues in general, whereas in the brain of AD patients, especially in brain regions closely associated with clinical symptoms, such as the hippocampus, the expression level of BC200 is significantly elevated. The gene discussed is BCYRN1; the disease is Alzheimer disease.